Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA (INDUZIDO QUIMICAMENTE), NEFROPATIAS (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, RESUMOS (EVENTOS)
ABNT
CASTRO, M S de et al. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2010APA
Castro, M. S. de, Fanelli, C., Poppi, E. P. B., Fernandes, B. H. V., Machado, F. G., Malheiros, D. M. A. C., et al. (2010). High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.NLM
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2024 out. 02 ]Vancouver
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2024 out. 02 ]